- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02044484
HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission (APTcare)
Study Overview
Detailed Description
This study examines the effect of an HIV clinic-based multi-component intervention on HIV patients' subsequent viral load status and attendance for HIV primary care. The intervention has clinic-wide and targeted components. The clinic-wide components are given to all HIV patients when they attend clinic for primary care and include: (1) patient behavioral screening used by providers in the clinical care of patients and (2) dissemination of palm cards which contain messages about the importance of adhering to antiretroviral therapy (ART), coming to clinic regularly, and safer sex. The targeted components focus on patients whose viral loads exceed 1000 copies/mL. Targeted components include: (1) an interactive computer-based intervention (CBI) completed twice (separated by 2-4 months) by patients at the clinic and (2) referral for one-on-one counseling from trained project Health Coaches if the patient's viral load does not show a 1-log reduction after the first CBI or remains above 200 copies/mL after two administrations of the CBI.
Patients are not individually randomly assigned to arms. The multi-component intervention is evaluated using a group-randomized design. Clinics were randomized to either Panel A or Panel B with the intent of equating the two panels on the percentage of patients with suppressed viral load prior to implementing the intervention. Three clinics (Panel A) begin intervention activities, and the other three clinics (Panel B) delay onset of all intervention activities for 16 months and thus serve as a concurrent control group during that 16-month period. This enables between-panel comparisons of the outcomes during this time interval.
The primary analytic cohort for the group-randomized analysis will be all patients in Panel A and Panel B whose viral load exceeds 1000 copies/mL who have a scheduled primary care appointment during a 7-month enrollment period. Viral load eligible patients in Panel A will be part of the analytic cohort regardless of whether they enroll in the CBI or not. These viral load eligible patients represent the group of patients who are targeted for the main intervention components (CBI and counseling) and, accordingly, will comprise the denominator (estimated to be 2,794) for the primary analysis of the viral load and clinic attendance outcomes. Each cohort member in Panel A is followed for 9 months for purpose of delivering the intervention and assessing the outcomes. Each cohort member in Panel B is followed for 9 months for purpose of assessing the outcomes.
Two secondary levels of analysis will also be performed. First, analysis will be performed focusing on all patients in Panel A clinics who have a viral load over 1000 copies/mL and received at least one administration of the CBI ("as-treated" approach). Outcomes of these patients will be compared to patients in Panel B whose viral load exceeds 1000 copies/mL during the recruitment period. Second, an analysis will be performed at the clinic-wide level including all patients in Panel A clinics regardless of viral load level who are scheduled for primary care during the recruitment period. Outcomes of these patients will be compared to all patients in Panel B scheduled for primary care visits during the recruitment period.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Brimingham, Alabama, United States, 35294
- Recruiting
- 1917 Clinic
-
Contact:
- Michael J Mugavero, MD
- Phone Number: 205-996-5822
- Email: mmugavero@uab.edu
-
Principal Investigator:
- Michael J Mugavero, MD
-
-
California
-
San Diego, California, United States, 92103
- Not yet recruiting
- Owen Clinic
-
Contact:
- Edward Cachay, MD
- Phone Number: 619-543-3995
- Email: ecachay@ucsd.edu
-
Principal Investigator:
- Edward Cachay, MD
-
-
Florida
-
Miami, Florida, United States, 33136
- Not yet recruiting
- Jackson Memorial Hospital
-
Contact:
- Allan E Rodriguez, MD
- Phone Number: 305-243-3011
- Email: ARodriguez2@med.miami.edu
-
Principal Investigator:
- Allan E Rodriguez, MD
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Not yet recruiting
- Boston Medical Center
-
Contact:
- Margaret Sullivan, MD
- Phone Number: 617-414-3574
- Email: meg.sullivan@bmc.org
-
Principal Investigator:
- Margaret Sullivan, MD
-
-
Texas
-
Houston, Texas, United States, 77009
- Recruiting
- Thomas Street Health Center
-
Contact:
- Thomas P Giordano, MD
- Phone Number: 713-794-8682
- Email: tpg@bcm.edu
-
Principal Investigator:
- Thomas P Giordano, MD
-
-
Washington
-
Seattle, Washington, United States, 98104
- Recruiting
- Harborview Medical Center
-
Contact:
- Shireesha Dhanireddy, MD
- Phone Number: 206-744-5103
- Email: sdanir@u.washington.edu
-
Sub-Investigator:
- Shireesha Dhanireddy, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients are eligible to receive behavioral screening and palm cards
- Patients with viral load exceeding 1000 copies/mL are eligible for the computer-based intervention and referral to counseling
Exclusion Criteria:
- Patients under the age of 18 (under 19 in Alabama) are not eligible for the computer-based intervention or referral to counseling because they cannot provide legal informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multi-component intervention
Computer-based intervention (CBI) completed twice (separated by 2-4 months) among patients whose viral load exceeds 1000 copies/mL at time of enrollment. One-on-one counseling from a project Health Coach (three 1-hour sessions at the clinic and two follow-up phone calls at 1 and 3 months after last session). The counseling is offered to patients who do not show a 1-log reduction in their viral load after the first CBI or whose viral load remains above 200 copies/mL after two administrations of the CBI. Behavioral screening of patients at HIV primary care visits. Dissemination of palm cards with empowering messages at HIV primary care visits. |
The computer-based intervention (CBI) is offered to patients whose viral load exceeds 1000 copies/mL at enrollment. Counseling is offered to patients whose viral load does not drop 1-log after the first CBI or remains above 200 copies/mL after completing two CBIs. The behavioral screener will be conducted of all patients at primary care visits. The patient completes the screener before seeing the provider. Responses are given to their provider who can use it in clinical care of the patient. At primary care visits, all patients are given a palm card containing 1 of 15 empowering messages before they leave the clinic. Messages cover three domains: adhering to antiretroviral therapy, regular care, and safer sex. |
No Intervention: Standard of care control
HIV patients will continue to receive existing standard of care practices at the clinic without receiving the multi-component intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage of patients with suppressed HIV (≤ 200 copies/mL)
Time Frame: At 9-month time point
|
At 9-month time point
|
Percentage of patients without a gap in HIV primary care (without a gap > 6 months)
Time Frame: From baseline to 9-month time point
|
From baseline to 9-month time point
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change across time in log10 viral load values
Time Frame: From baseline to 9-month time point
|
From baseline to 9-month time point
|
|
HIV primary care appointment adherence
Time Frame: From baseline to 9-month time point
|
Proportion of scheduled HIV primary care appointments kept (omitting prior cancellations) per patient
|
From baseline to 9-month time point
|
Collaborators and Investigators
Investigators
- Principal Investigator: Thomas P Giordano, MD, Baylor College of Medicine
- Principal Investigator: Margaret Sullivan, MD, Boston University
- Principal Investigator: Matthew Golden, MD, University of Washington
- Principal Investigator: Edward Cachay, MD, University of California, San Diego
- Principal Investigator: Michael J Mugavero, MD, University of Alabama at Birmingham
- Principal Investigator: Allan E Rodriguez, MD, University of Miami
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CDC-NCHHSTP-2468
- CDC (CDC)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
Clinical Trials on Multi-component intervention
-
George Washington UniversityActive, not recruitingPrEP | HIV Risk PerceptionUnited States
-
University of Southern DenmarkActive, not recruitingNeck Pain | Shoulder Pain | Lifestyle
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruiting
-
HBSARecruitingBinge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related HarmsUnited States
-
María AhijónInstituto de Salud Musculoesquelética SLCompleted
-
Singapore General HospitalSengkang General Hospital; Sengkang Community Hospital; Outram Community HospitalEnrolling by invitationStroke | Implementation ScienceSingapore
-
The University of QueenslandUS Department of Veterans AffairsUnknownDepression | Posttraumatic Stress Disorder
-
University of California, San DiegoCity of Hope Medical Center; Rady Children's Hospital, San DiegoRecruitingCancer | Fertility PreservationUnited States
-
University of PittsburghDuke University; National Institute on Aging (NIA); Oregon Health and Science... and other collaboratorsRecruiting
-
University of California, San DiegoCancer Resource Center of the Desert; El Centro Regional Medical Center; Pioneers...RecruitingBreast Cancer | Contraception | Menopausal Symptoms | FertilityUnited States